National Institute of Neurological Disorders and Stroke; Amended Notice of Meeting, 80320 [2023-25403]

Download as PDF khammond on DSKJM1Z7X2PROD with NOTICES 80320 Federal Register / Vol. 88, No. 221 / Friday, November 17, 2023 / Notices Non-voting Federal Liaisons, without limit, may be solicited, as needed, as ex officio members. Equal opportunity practices regarding membership appointments to the Committee will be aligned with HHS policies. To the extent possible, HHS will ensure the Committee membership is balanced in expertise, experience, education, and institutional affiliation. Members of the Committee will be classified as Special Government Employees (SGE) during their term of appointment and, as such, are subject to the ethical standards of conduct for federal employees. Upon entering the position and annually throughout the term of appointment, members of the Committee will be required to complete and submit a report of their financial holdings. Nominations and Appointments for Memberships: Nominees, including selfnominees, will be considered for appointment as members of the Committee. Only complete nomination packages submitted on time will be considered. To be considered for an appointment, submission of the following information for each nominee is required: (1) a cover letter that clearly states the name and place of work of the nominee, the rationale for the nomination, and a statement that the nominee would be willing to serve as a member of the Committee, if selected; (2) the name, address, telephone number, and email address for the individual being nominated and the nominator, if applicable; and (3) a copy of the nominee’s resume or curriculum vitae. Nominees with no professional affiliation may submit an optional letter of recommendation. The curriculum vitae should include the following information: (a) education; (b) experience (current and former); (c) affiliations; (d) current memberships (expert panels, committees, or other relevant groups, including positions held); (e) any peer-reviewed publications (for past 5 years); (f) any oral presentations (for past 5 years); (g) editorials, opinion pieces, and blogs (for past 5 years); (h) grants, contracts, or research funding (for past 15 years); (i) name of any corporation, professional society, association, panel, company, firm, government agency (Federal, State, and local), research organization, educational institution, committee, or other organization or institution (government, private, and not-for-profit; domestic and foreign) in which the nominee’s services have been, will be, or are expected to be provided, with or without compensation, including on a part-time or seasonal basis as an officer, medical staff, board member, owner, VerDate Sep<11>2014 18:57 Nov 16, 2023 Jkt 262001 trustee, director, expert advisor, consultant (paid or unpaid), official spokesperson, member of speakers bureau, or expert witness (for past 5 years and upcoming); (j) other paid travel or honoraria received, not included above (for past 5 years). If the nominee does not have anything to report for the sections, indicate ‘‘none.’’ Web links to publications, presentations, and other materials available online are requested, when available. Where prohibited by Federal law or regulations, nominations will not be accepted directly from HHS research and promotion boards. Self-nominations and nominations by members of research and promotion boards in their individual capacity will be considered. Federal employees should not be nominated for consideration for appointment to this Committee. Dated: November 2, 2023. Xavier Becerra, Secretary, Department of Health and Human Services. [FR Doc. 2023–24586 Filed 11–16–23; 8:45 am] BILLING CODE 4150–03–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Neurological Disorders and Stroke; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the National Institute of Neurological Disorders and Stroke Special Emphasis Panel, November 27, 2023, 09:00 a.m. to November 29, 2023, 06:00 p.m., Crowne Plaza National Airport, 1480 Crystal Drive, Arlington, VA 22202 which was published in the Federal Register on September 25, 2023, 88 FR 67334. This notice is being amended to change the location to Canopy by Hilton, 940 Rose Avenue, North Bethesda, MD 20852, and change the meeting times to 10:00 a.m. to 6:00 p.m. The meeting dates remains the same. The meeting is closed to the public. Dated: November 13, 2023. David W. Freeman, Supervisory Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2023–25403 Filed 11–16–23; 8:45 am] BILLING CODE 4140–01–P PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of the Director, National Institutes of Health; Amended Notice of Meeting Notice is hereby given of an amended meeting notice of the Advisory Committee to the Director, National Institutes of Health, December 14–15, 2023, open meeting that was published in the Federal Register on November 13, 2023, 88 FR 77595. Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the Advisory Committee to the Director, National Institutes of Health. This will be a hybrid meeting held inperson and virtually and will be open to the public as indicated below. Members of the public are encouraged to attend virtually as space is limited. Individuals who plan to attend as well as those who need special assistance or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting can be accessed from the NIH Videocast at the following link: https:// videocast.nih.gov/ as space is limited. Name of Committee: Advisory Committee to the Director, National Institutes of Health. Date: December 14, 2023. Time: 9:00 a.m. to 4:45 p.m. Agenda: NIH Director’s Report; NIH Public Access Plan; Cancer Moonshot; Addressing the Mental Health Crisis through Research; Assessing the Public Health Threat of PostAcute Sequelae of SARS CoV–2 Infection (PASC)—NIH RECOVER Initiative: Briefing for the Advisory Committee to the Director (ACD); The Foundation for the National Institutes of Health (FNIH); Other Business of the Committee. Date: December 15, 2023. Time: 9:00 a.m. to 2:45 p.m. Agenda: HeLa Genome Data Access Working Group: Data Access Requests; NIHWide Collaborative Initiative on Climate Change and Health; Clinical Trial Stewardship; Accessibility Update; Update from the ACD Working Group on Catalyzing the Development and Use of Novel Alternative Methods to Advance Biomedical Research; Update from the ACD Working Group on Re-envisioning NIH-Supported Postdoctoral Training; Other Business of the Committee. Place: National Institutes of Health, Building 1, Wilson Hall, One Center Drive, Bethesda, MD 20892. Contact Person: Cyndi Burrus-Shaw, Staff Assistant, National Institutes of Health, Office of the Director, One Center Drive, Building 1, Room 126, Bethesda, MD 20892, 301–496–2433, shawcy@od.nih.gov E:\FR\FM\17NON1.SGM 17NON1

Agencies

[Federal Register Volume 88, Number 221 (Friday, November 17, 2023)]
[Notices]
[Page 80320]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-25403]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Neurological Disorders and Stroke; Amended 
Notice of Meeting

    Notice is hereby given of a change in the meeting of the National 
Institute of Neurological Disorders and Stroke Special Emphasis Panel, 
November 27, 2023, 09:00 a.m. to November 29, 2023, 06:00 p.m., Crowne 
Plaza National Airport, 1480 Crystal Drive, Arlington, VA 22202 which 
was published in the Federal Register on September 25, 2023, 88 FR 
67334.
    This notice is being amended to change the location to Canopy by 
Hilton, 940 Rose Avenue, North Bethesda, MD 20852, and change the 
meeting times to 10:00 a.m. to 6:00 p.m. The meeting dates remains the 
same. The meeting is closed to the public.

    Dated: November 13, 2023.
David W. Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee 
Policy.
[FR Doc. 2023-25403 Filed 11-16-23; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.